Company Directory > Pharma > Torrent Pharmaceuticals
Torrent Pharmaceuticals is the flagship company of the Torrent Group and one of the leading pharmaceutical companies in India. It pioneered the concept of niche marketing in India and is a dominant player in the therapeutic segments of Cardiovascular (CVS), Central Nervous System (CNS), Gastro-intestinal (GI), and Vitamins Minerals Nutritionals (VMN). The company has a significant global footprint, with a presence in over 50 countries and a leading position among Indian pharma companies in Brazil and Germany. Torrent operates state-of-the-art R&D and manufacturing facilities that are accredited by international regulatory bodies including the USFDA, EMA, and ANVISA.
CLASSIFICATION
Company Type:Pharma
Industry:Pharmaceuticals
Sub-Industry:Branded Generics and NCE Research
SIZE & FINANCIALS
Employees:10000+
Revenue:$1.3B-$1.5B
Founded:1972
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:KKR (via JB Chemicals deal), Public Shareholders
STOCK
Exchange:NSE
Ticker:TORNTPHARM
Market Cap:$14.5B
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 2
Modalities:Small molecule, Biosimilar, Complex Generics
Active Trials:158
Trial Phases:Phase 1: 12 | Phase 2: 8 | Phase 3: 5 | Phase 4: 20
FDA Approvals:120
EMA Approvals:45
CORPORATE STRUCTURE
Parent Company:Torrent Group
Subsidiaries:Heumann Pharma (Germany), Torrent do Brasil, Torrent Pharma Inc. (USA), JB Chemicals and Pharmaceuticals (Acquired 2025)
Key Partnerships:Novartis (Women healthcare brands acquisition), Reliance Life Sciences (Biosimilar collaboration)
COMPETITION
Position:Leader
Competitors:Sun Pharma, Cipla, Dr. Reddy's Laboratories, Lupin, Zydus Lifesciences
LEADERSHIP
Key Executives:
Samir Mehta - Chairman
Aman Mehta - Managing Director
Scientific Founders:U.N. Mehta
Board Members:Samir Mehta, Aman Mehta, Ameera Shah, Nikhil Khattau
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Torrent Pharmaceuticals. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.